Streetbeat News

Price Targets

IMVT

HC Wainwright & Co. analyst Douglas Tsao has reaffirmed a Buy rating on Immunovant (NASDAQ:IMVT) and increased the price target from $47 to $51.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 11:09 am

IVA

HC Wainwright & Co. analyst Ed Arce has maintained a Buy rating on Inventiva (NASDAQ:IVA) but has reduced the price target from $36 to $24. This adjustment reflects a change in valuation but still suggests confidence in the company's potential.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 11:07 am

FURY

HC Wainwright & Co. analyst Heiko Ihle has reaffirmed a Buy rating on Fury Gold Mines (AMEX:FURY) and increased the price target from $1.4 to $1.5.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 11:04 am

CRWD

Needham analyst Alex Henderson has reaffirmed a Buy rating on CrowdStrike Holdings (NASDAQ:CRWD) and increased the price target from $250 to $325.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 11:02 am

MU

Mizuho analyst Vijay Rakesh has maintained a Buy rating on Micron Technology (NASDAQ:MU) and increased the price target from $86 to $95, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 11:00 am

MU

Goldman Sachs analyst Toshiya Hari has reaffirmed a Buy rating on Micron Technology (NASDAQ:MU) and increased the price target from $85 to $97, signaling confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 10:59 am

PNT

Brookline Capital analyst Kemp Dolliver downgraded POINT Biopharma Global (PNT) from Buy to Hold and reduced the price target from $27 to $12.5.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 10:47 am

ROL

Morgan Stanley analyst Toni Kaplan has initiated coverage on Rollins (NYSE:ROL) with an Equal-Weight rating and set a price target of $42 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 10:46 am

FROG

Morgan Stanley analyst Sanjit Singh has upgraded JFrog (NASDAQ:FROG) from Equal-Weight to Overweight and increased the price target from $32 to $42.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 10:43 am

CRM

Morgan Stanley analyst Keith Weiss has upgraded Salesforce (NYSE:CRM) from Equal-Weight to Overweight and increased the price target from $290 to $350.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 10:41 am